CLINICAL_TRIALS
trial_result
· 2013-06-25
Clinical Trial Update: Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
Summary
This phase 2 trial evaluated the combination of chemotherapy with interferon alfa for chronic myeloid leukemia and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED